Carsten Hopf is a Professor of Bioanalytics and Drug Discovery at Mannheim University of Applied Sciences, leading the Institute of Instrumental Analytics and Bioanalytics and the CeMOS (Center for Mass Spectrometry and Optical Spectroscopy). His work focuses on developing spatially resolved omics technologies (e.g., MALDI-MS imaging) for neurodegenerative and oncological research. He explores lipidomics, proteomics, and metabolomics to understand Alzheimer's disease, glioblastoma, and other neurodegenerative disorders. Key projects include the SMART-CARE-2 BMBF initiative (2023–2026) and DFG-funded research on spatial multi-omics in glioblastoma (SFB 1389). Research interests center on mass spectrometry innovations, including matrix optimization, AI-driven data analysis, and multimodal imaging (e.g., infrared microscopy integration). His lab develops label-free cell assays for drug discovery and studies molecular mechanisms of neurodegeneration. Collaborations span academia and industry, with projects like the M 2 Aind partnership addressing 3D cell culture toxicity assessments. Grants include BMBF, DFG, and EU funding for systems medicine, organoid analysis, and mass spectrometry cores. His technological advancements aim to improve biomarker discovery and translational medicine in neuro-oncology and neurodegeneration.
Mark A. Hayes is an Associate Professor at Arizona State University's School of Molecular Sciences, where he conducts interdisciplinary research spanning analytical chemistry, microfluidics, and bioanalytical technologies. He earned his Ph.D. from Pennsylvania State University in 1993. His research focuses on developing micro/nanofluidic platforms for ultrasmall-volume biological analysis, aiming to enable early disease detection through predictive pattern recognition. Key areas include: Dielectrophoresis for protein/cell separation Microfluidic biosensor design Surface chemistry and interfacial phenomena Pathogen isolation and characterization Recent publications (2017-2021) demonstrate strong emphasis on dielectrophoretic separation mechanisms, microdevice optimization for biomedical applications, and theoretical modeling of electrokinetic phenomena. His work frequently integrates experimental validation with computational approaches. He has mentored 60+ students (including 16 doctoral graduates) and secured research funding from NIH, NSF, and industry partners. Current projects include pathogen isolation platforms, biomarker concentration technologies, and electrophoretic separation systems.
Paul D. Adams is a Professor in the Department of Chemistry & Biochemistry at the University of Arkansas, affiliated with the College of Arts & Sciences. His research focuses on protein structure, dynamics, and interactions using advanced biophysical techniques. Professional Affiliations : Arkansas Biosciences Institute, National Organization of Black Chemists and Chemical Engineers, Protein Society, Sigma Xi Scientific Research Society, Arkansas Academy of Sciences, Biophysical Society. Research Interests : Dr. Adams specializes in multidimensional NMR spectroscopy for protein structure determination and dynamics. His work explores intramolecular motions in proteins, biochemical characterization of protein-protein interactions (PPIs), and the impact of small molecule targets on PPIs. Techniques include steady-state and time-resolved fluorescence spectroscopy, isothermal titration calorimetry (ITC), differential scanning calorimetry (DSC), circular dichroism (CD), and post-column amino acid analysis. Publication Trends : His recent articles focus on Ras family GTPases (Cdc42, Ras mutants), copper-binding domains in nonclassical secretion, calorimetry applications in biomolecular interactions, and structural characterization of protein mutants. Keywords span biophysics, cancer biology, and analytical techniques. Scientific Awards : NSF Minority Postdoctoral Fellow Robert C. and Sandra Connor Endowed Faculty Fellow, Fulbright College of Arts and Sciences Teaching : Dr. Adams teaches biochemistry and has contributed to graduate education. His lab supports research training in NMR spectroscopy and biophysical methods.
Sean Palecek is the Milton J. and A. Maude Shoemaker Professor in the Department of Chemical and Biological Engineering at the University of Wisconsin–Madison. His research focuses on engineering platforms to regulate human pluripotent stem cell (hPSC) differentiation for cardiovascular and neurovascular applications. He is based in 3637 Engineering Hall and leads the Palecek Lab, which develops innovative methods for stem cell fate specification and tissue engineering. BChE, Chemical Engineering, University of Delaware MS, Chemical Engineering, University of Illinois at Urbana-Champaign PhD, Chemical Engineering, Massachusetts Institute of Technology Postdoc., Molecular Genetics and Cell Biology, University of Chicago His research integrates stem cell biology with biomaterials and engineering principles to generate functional cardiomyocytes, brain endothelial cells, and mural cells. His lab leverages Notch3 signaling, proteomics, and organoid systems to model diseases and develop regenerative therapies. Current projects emphasize hypoimmunogenic cardiac organoids, vascular grafts, and blood-brain barrier models for neurotherapeutic screening. The 15 most recent articles highlight his work in human pluripotent stem cell (hPSC) differentiation to cardiomyocytes, endothelial cells, and brain mural cells. Key trends include organoid manufacturing , neurovascular unit modeling , metabolic profiling , and biomaterials for cell transport . His team explores Notch3 activation, SNRK signaling, and transcriptional analysis to optimize cell therapy and disease models. Scientific contributions include the Milton J. and A. Maude Shoemaker Professorship, a named chair recognizing his leadership in chemical and biological engineering. For more details, visit his lab’s website: Palecek Lab .
Joshua Rabinowitz is a Professor of Chemistry and Director of the Ludwig Princeton Branch at Princeton University. His research focuses on quantitative analysis of cellular metabolism, leveraging advanced mass spectrometry and computational modeling. Key areas include metabolic regulation in microbes (E. coli, yeast), cancer cell metabolism, viral infection impacts, and biofuel production. His lab has pioneered methods to measure metabolites and fluxes, leading to discoveries like novel cancer metabolites and antiviral strategies via fatty acid inhibition. Notable honors include the NIH Pioneer Award and Agilent Thought Leader Award. Research emphasizes systems-level understanding, with projects combining biological experiments, metabolomics, and computation. Recent work explores metabolic heterogeneity in humans, immunotherapy enhancements through metabolic modulation, and metabolic vulnerabilities in cancers like rhabdomyosarcoma. Collaborations include engineering yeast for biofuel production and developing therapeutics targeting metabolic pathways. Lab Website: Rabinowitz Lab Affiliations: Lewis-Sigler Institute for Integrative Genomics, Princeton University Major contributions include identifying metabolic shifts in viral infections, modeling microbial nutrient responses, and advancing technologies for metabolite quantification. Current efforts aim to integrate metabolomic data with enzyme regulation dynamics to predict metabolic networks across organisms.
Jacqueline Smith is an Associate Professor in the Department of Chemistry at Howard University's College of Arts & Sciences. Her research program focuses on developing small-molecule therapeutics and bioanalytical tools for cancer and neurological diseases, with a strong emphasis on organic synthesis and drug discovery. Dr. Smith earned her Ph.D. in Chemistry from the University of Maryland, College Park, and completed postdoctoral research at Georgetown University. She is deeply committed to STEM outreach and education, particularly in supporting underrepresented minorities in organic chemistry. Ph.D. in Chemistry, University of Maryland, College Park (2011) B.S., University of Maryland, Baltimore County (UMBC), Meyerhoff Scholarship Program Postdoctoral Research, Georgetown University, Drug Discovery Lab Her research interests lie at the intersection of Organic Synthesis , Chemical Biology , and Drug Discovery , with specific focus on microwave-assisted synthesis of imidazole compounds to combat cancer resistance, and the development of fluorescent theranostic agents for targeted drug delivery and imaging, particularly in triple-negative breast cancer and brain delivery. She also explores quorum sensing modulation in bacterial systems. Her recent publications reveal a consistent trend in leveraging synthetic chemistry to address complex biological problems, spanning cancer therapeutics, neurodegenerative disease, and antimicrobial strategies. The work combines methodological innovation in synthesis with rigorous biological evaluation, demonstrating a translational and interdisciplinary approach. Dr. Smith has been recognized with prestigious awards, including: NSF CAREER Award NSF EiR Award She has actively mentored over 30 undergraduate and high school students and has secured significant research funding. Her lab operates at the forefront of chemical biology, developing novel tools and therapies. The Smith Research Lab is a dynamic team working on innovative projects in cancer resistance , theranostic drug delivery , and bacterial communication .
Katia Gallo is a Professor at the Department of Applied Physics, KTH Royal Institute of Technology, where she leads the Nonlinear and Quantum Photonics Group. She is actively involved in national and European quantum initiatives, including directing the Quantum Communication program in the Swedish Quantum Flagship (WACQT) and the National Quantum Communication Infrastructure (NQCIS) under EuroQCI. Her academic affiliations are centered at KTH, with prior research experience at the Optoelectronics Research Centre in Southampton, UK. Education: MSc in Electronic Engineering, University ‘La Sapienza’, Rome, Italy (1997) PhD in Electronic Engineering (joint with Stanford University, USA) PhD in Physics, University of Nice-Sophia Antipolis, France (2001) Her research focuses on nonlinear and quantum photonics , with core interests in integrated optics, ferroelectric materials, quantum optics, and biophotonics. She investigates the fundamental physics and applications of nonlinear wave interactions in photonic circuits, particularly using lithium niobate platforms. Her work spans from theoretical modeling to experimental realization of devices for all-optical signal processing, quantum communication, and sensing. She has made significant contributions to the development of thin-film lithium niobate photonic devices, including grating filters, superconducting detectors, and wavelength-sensitive systems. Her recent publications (2017–2024) reflect a strong trend toward integrated quantum photonics , nanophotonic devices on lithium niobate , and biophotonic applications . Key themes include electro-optic tuning, superconducting single-photon detection, nonlinear frequency conversion, and surface-enhanced Raman scattering for sensing. The interdisciplinary nature of her work bridges physics, engineering, and materials science. Scientific Awards and Recognitions: Swedish Research Council Senior Fellowship EU Marie Curie Fellowships (TMR and Intra-European) Leverhulme Trust Early Career Fellowship London Technology Network Business Fellowship Centre and South Italy IEEE Student Award KTH Rektor Prize for Equality and Diversity Katia Gallo is deeply involved in academic service, serving as course responsible and examiner for key courses such as Applied Modern Physics , Fundamentals of Photonics , and Quantum Technology . She mentors students and leads a research group focused on advancing photonic technologies. Her leadership extends to major national and European quantum infrastructure projects, positioning her at the forefront of quantum communication development in Sweden and Europe. She leads the Nonlinear and Quantum Photonics Group at KTH, which conducts cutting-edge research in nonlinear optical phenomena, quantum photonics, and integrated photonic devices. The group works on both theoretical and experimental aspects, utilizing advanced fabrication and characterization techniques to develop next-generation photonic technologies.
Professor Stephen Clarke is a distinguished academic and clinician at the University of Sydney, affiliated with the Medicine, Northern Clinical School and the Kolling Institute of Medical Research. He holds the title of Professor of Medicine and specializes in oncology, with a focus on cancer pharmacology, colorectal and lung cancers. His research integrates clinical trials, translational research, and the exploration of biomarkers and therapeutic strategies in oncology. Professor Clarke’s work spans diverse areas including the use of imaging techniques (e.g., PET/CT), precision medicine, and the impact of systemic inflammation on cancer outcomes. He has contributed to advancements in targeted therapies, immunotherapy, and supportive care, including studies on cannabis-based pain management. His research interests also extend to the gut microbiome’s role in cancer treatment response and toxicities, as well as the development of probiotic interventions to mitigate treatment side effects. He has led or collaborated on numerous clinical trials, including studies of stereotactic body radiotherapy for pancreatic cancer and immunotherapy combinations in lung cancer. Professor Clarke has been recognized with the Order of Australia Medal (OAM) for his contributions to medicine. His publications emphasize translational research, with a focus on improving patient outcomes through evidence-based approaches in oncology.
Dr. Can Dincer is the head of the "Disposable Microsystems" junior research group at the FIT Freiburg Center for Interactive Materials and Bio-Inspired Technologies and the Institute of Microsystems Engineering (IMTEK) at the University of Freiburg. He earned his doctorate in Microsystems Engineering from the University of Freiburg in 2016 with a thesis on electrochemical microfluidic biosensors for point-of-care testing, earning the Gips-Schüle Young Researchers Award (2nd place, 2017). From 2017–2019, he worked as a visiting scientist at Imperial College London, focusing on paper-based microfluidic systems. He is an Associate Editor of Biosensors and Bioelectronics since 2019 and has received multiple accolades, including the 2018 Adolf Martens Prize, the 2020 iba Heiligenstadt Best Paper Award, and the 2021 Biosensors & Bioelectronics Best Paper Award. His research emphasizes microfluidic diagnostics, disposable sensors, and CRISPR-powered biosensing technologies. Research Interests: Microfluidic diagnostics and lab-on-a-chip systems Paper-based µPADs for point-of-care testing CRISPR-integrated biosensors for nucleic acid detection Personalized medicine via miRNA profiling Respiratory gas analysis microsystems Awards: Highlighted in ACS Sensors' 'Rising Stars in Sensing' (2020), elected to the International Advisory Board of Advanced Sensor Research (2022), and recognized for pioneering work in electrochemical biosensor optimization. Grants/Labs: Leads the Disposable Microsystems Group, collaborating on projects like BioEPIC and SPEEDER, focusing on biofunctional materials and nerve regeneration technologies.
Rutilio A. Fratti is a Professor of Biochemistry and Biophysics & Quantitative Biology at the University of Illinois, affiliated with the College of Liberal Arts & Sciences and the School of Molecular & Cellular Biology. His research focuses on protein-lipid interactions, membrane fusion, and lipid metabolism, particularly in the context of diseases like cancer, diabetes, and Alzheimer's. He earned his B.S. from California State University, Long Beach (1992), Ph.D. from the University of Michigan (2002), and completed postdoctoral work at Dartmouth Medical School (2002-2006). Key research interests include regulatory lipids (e.g., phosphatidic acid, phosphoinositides) and their roles in membrane microdomains, SNARE protein function, and drug discovery targeting fungal pathogens. His lab uses yeast vacuoles and synthetic vesicles to study lipid-protein interactions during membrane fusion. Publications highlight advancements in methods like Bio-Layer Interferometry, microscale thermophoresis, and spectroscopic techniques for studying lipid-protein interactions. Collaborations span drug discovery (e.g., SQ109 antifungal mechanisms) and mechanistic insights into Sec18 protein dynamics and Ypt7 regulation. Affiliated with the Center for Biophysics & Quantitative Biology, his work bridges fundamental lipid biology with translational applications in metabolic and infectious diseases.
Dr. Haobo Ge is a Postdoctoral Research Associate at the Department of Life Sciences , University of Bath, affiliated with the Centre for Bioengineering & Biomedical Technologies (CBio) . Active in interdisciplinary research spanning nanomaterials and biomedical imaging, his work addresses cellular protection mechanisms and oxidative stress-related diseases. Specializes in fluorescence lifetime imaging and theranostic molecular probes Active in UN Sustainable Development Goals related to health and well-being Research Interests focus on nanostructured materials, particularly carbon nanotubes and nanohybrids, for biomedical applications. Key areas include ferroptosis regulation, multiphoton imaging, and antioxidant therapies. His work intersects bioengineering, material science, and pharmacology. Recent Publications highlight advancements in two-photon fluorescence lifetime microscopy, therapeutic combinations for neurodegenerative diseases, and functional molecular probes for cellular imaging.
Christopher J. Easley is the C. Dent Williams Professor of Bioanalytical Chemistry at Auburn University's Department of Chemistry and Biochemistry. He leads the Easley Lab, focusing on developing novel microanalytical techniques for studying endocrine tissue function and biosensing. His roles include ADR Fellow, Graduate Program Officer, and Associate Editor for Analytical Methods . Easley earned his Ph.D. from the University of Virginia (2006) and B.S. from Mississippi State University (2002), with postdoctoral training at Vanderbilt University Medical Center. Affiliations: College of Sciences and Mathematics (COSAM), Royal Society of Chemistry (Associate Editor) Research interests include droplet microfluidics for tissue secretion analysis, cooperative DNA-based biosensors, and electrochemical detection platforms. His lab's work spans analytical chemistry, molecular biology, and device engineering. Key publications (2020–2024) focus on adipose tissue dynamics, electrochemical proximity assays, and µChopper device innovations. Awards include the Dean's Faculty Research Award (2020) and AES Mid-Career Achievement (2019). Current students include Andresa Bezerra (Ph.D. candidate) and Sabita Dangol. Former students have transitioned to roles at institutions like South China Normal University and QPS Holdings. The lab's funding sources include NIH (R01 grants), NSF, and Auburn University's Intramural Grants Program. Lab infrastructure includes specialized microfluidic devices, electrochemical setups, and collaborations with Vanderbilt and UCSF researchers.
Matthew Campbell is a Research Fellow at Curtin University's School of Molecular and Life Sciences (MLS), part of the Faculty of Science and Engineering. He is affiliated with the Curtin Medical Research Institute (Curtin MRI) and holds office in Room 201 at Curtin Perth campus. His research focuses on environmental DNA (eDNA), ancient DNA (aDNA), microbial ecology, and hypersaline/extreme environment studies. Key projects include investigating coastal-marine ecosystems through sedimentary aDNA, groundwater keystone ecosystems, and microbial community responses to environmental stressors like salinity and cyclones. Research emphasizes integrative approaches combining eDNA metabarcoding with traditional ecological methods, particularly in hypersaline lakes (e.g., Rottnest Island), arid zone calcretes, and anchialine sinkholes. His work bridges microbiology, geochemistry, and conservation biology, addressing topics like threatened species detection (e.g., Pilbara olive python), climate change impacts on microbial communities, and ecosystem function in extreme environments. Campbell collaborates extensively with international teams on projects ranging from Australian coastal systems to Indonesian Lake Towuti. Publications reflect a strong focus on method development for eDNA sampling (e.g., spider webs as novel matrices) and interdisciplinary applications of DNA-based techniques to understand ecosystem dynamics. His work contributes to both fundamental ecological understanding and applied conservation strategies. No major scientific awards are explicitly mentioned in the provided texts.
Diana S-L. Chow is a Professor in the Department of Pharmacological and Pharmaceutical Sciences at the University of Houston College of Pharmacy . She also holds the Paula & John J. Lovoi Sr. Endowed Professor in Drug Discovery and Development and serves as Director of the Institute of Drug Education and Research . B.S. in Pharmacy, National Taiwan University, School of Pharmacy M.S. in Natural Product Chemistry, Ohio State University Ph.D. in Pharmaceutics, University of British Columbia Dr. Chow's research spans 40 years of translational drug development with a focus on anti-cancer therapies . She has pioneered formulations resulting in FDA-approved products like Busulfex® , with ongoing work on lung, pancreatic, and prostate cancer treatments. Her recent studies expand to underrepresented minority (URM) populations , pediatrics, and neurologically injured patients, emphasizing pharmacokinetics/pharmacodynamics (PK/PD) optimization. Her publications highlight expertise in analytical method development (e.g., LC-MS/MS assays), nanoparticle-based drug delivery , and neuroprotective agents . Key themes include preclinical-to-clinical translation , metabolite quantification , and bioavailability enhancement . 2023 Meritorious Achievement Award, UH College of Pharmacy 2023 Pharmaceutical Sciences Alumni Agent of Change, University of British Columbia 2016 Fellow, National Academy of Inventors 2009 Inventor of the Year, HIPLA Dr. Chow mentors extensively, with recognition as Outstanding Graduate Mentor (2022, 2021), and contributes to graduate education and research infrastructure through her directorship.
Professor Joohoon Kim is a distinguished faculty member in the Department of Chemistry at Kyung Hee University's College of Sciences in Seoul, Korea. With expertise in analytical chemistry and nanomaterials, he leads a research group focused on developing advanced electrochemical sensors and nanotechnology applications for chemical detection and biosensing. His educational background includes: Ph.D. in Analytical Chemistry, University of Texas at Austin, TX, 2007 M.S. in Analytical Chemistry, Seoul National University, Seoul, Korea, 2000 B.A. in Management, Korea National Open University, Seoul, Korea, 2003 B.S. in Chemistry Education, Seoul National University, Seoul, Korea, 1998 Professor Kim's research spans analytical chemistry, nanomaterials, and electrochemistry with emphasis on dendrimer-encapsulated nanoparticles, electrochemiluminescence, and surface modification techniques. His work has made significant contributions to electrochemical biosensors, DNA analysis platforms, and nanomaterial-based detection systems. The laboratory develops innovative approaches for chemical and biological sensing with applications in environmental monitoring and biomedical diagnostics. His publication record shows consistent innovation in graphene-based materials, dendrimer-nanoparticle composites, and electrochemiluminescence applications. The research demonstrates sophisticated surface modification techniques for enhanced electrochemical detection, particularly focusing on ITO electrodes modified with various nanomaterials for improved sensor performance while maintaining optical transparency. Professor Kim has received numerous prestigious awards: Korean Chemical Society - Division of Analytical Chemistry Chemistry Award for Young Analytical Chemist (2013) Korean Chemical Society - Division of Analytical Chemistry Distinguished Service Award (2011) American Chemical Society - Division of Analytical Chemistry Graduate Fellowship (2007) Membership Award in AAAS Program from Science Magazine (2006) LabAutomation Travel Award (2006) Professor Kim has mentored numerous graduate students through their Master's and PhD programs, with several successful graduates working at prominent Korean institutions including Samsung, LG, and SK. His research has been supported by various grants, including funding from the National Research Foundation of Korea as indicated by references to '한국연구재단 기초연구실' in his laboratory announcements. His laboratory at Kyung Hee University maintains active research in nanomaterial synthesis, electrochemical sensor development, and surface modification techniques, with facilities in Room 803 of the Space21 Science Building. The lab maintains collaborations with researchers both domestically and internationally, contributing to the advancement of analytical chemistry and nanotechnology applications.
